Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients

Detalles Bibliográficos
Autores principales: Liu, Esther C., Lee, Jennifer H., Loo, Angela, Mazur, Shawn, Sultan, Sam, Aull, Meredith, Lee, Jun B., Muthukumar, Thangamani, Hartono, Choli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418987/
https://www.ncbi.nlm.nih.gov/pubmed/34514186
http://dx.doi.org/10.1016/j.ekir.2021.08.032
_version_ 1783748671757615104
author Liu, Esther C.
Lee, Jennifer H.
Loo, Angela
Mazur, Shawn
Sultan, Sam
Aull, Meredith
Lee, Jun B.
Muthukumar, Thangamani
Hartono, Choli
author_facet Liu, Esther C.
Lee, Jennifer H.
Loo, Angela
Mazur, Shawn
Sultan, Sam
Aull, Meredith
Lee, Jun B.
Muthukumar, Thangamani
Hartono, Choli
author_sort Liu, Esther C.
collection PubMed
description
format Online
Article
Text
id pubmed-8418987
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84189872021-09-07 Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients Liu, Esther C. Lee, Jennifer H. Loo, Angela Mazur, Shawn Sultan, Sam Aull, Meredith Lee, Jun B. Muthukumar, Thangamani Hartono, Choli Kidney Int Rep Research Letter Elsevier 2021-09-06 /pmc/articles/PMC8418987/ /pubmed/34514186 http://dx.doi.org/10.1016/j.ekir.2021.08.032 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Liu, Esther C.
Lee, Jennifer H.
Loo, Angela
Mazur, Shawn
Sultan, Sam
Aull, Meredith
Lee, Jun B.
Muthukumar, Thangamani
Hartono, Choli
Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients
title Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients
title_full Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients
title_fullStr Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients
title_full_unstemmed Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients
title_short Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients
title_sort casirivimab-imdevimab (regn-cov2) for mild to moderate sars-cov-2 infection in kidney transplant recipients
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418987/
https://www.ncbi.nlm.nih.gov/pubmed/34514186
http://dx.doi.org/10.1016/j.ekir.2021.08.032
work_keys_str_mv AT liuestherc casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT leejenniferh casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT looangela casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT mazurshawn casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT sultansam casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT aullmeredith casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT leejunb casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT muthukumarthangamani casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients
AT hartonocholi casirivimabimdevimabregncov2formildtomoderatesarscov2infectioninkidneytransplantrecipients

Ejemplares similares